Literature DB >> 24573635

Effect of hypoxia on angiogenesis related factors in glioblastoma cells.

Marwan Emara1, Joan Allalunis-Turner1.   

Abstract

Pathological angiogenesis is a characteristic feature of glioblastoma multiforme (GBM) where the balance between pro-angiogenic and anti-angiogenic factors are shifted towards the pro-angiogenic phenotype. In this study we sought to determine whether angiostatins are expressed by GBM cells and whether their expression along with other related factors [matrix metalloproteinase (MMP)-2, MMP-9, and collagen type I α1 (COLIA1)] are altered by hypoxia and/or correlated with the levels of cancer stem cell marker CD133. Using qRT-PCR, western blotting, and gelatin zymography, we examined the expression of angiostatins, MMP-2, MMP-9, COLIA1 and CD133 in GBM cell lines cultured under aerobic conditions and hypoxia. Expression levels of MMP-2 and MMP-9 were significantly induced by hypoxia. Angiostatins were detected in all GBM cell lines and were increased by hypoxia while the angiostatin isoform of 38-kDa was the most abundant in GBM cells under aerobic and hypoxic conditions. COLIA1 and CD133 were significantly increased in several GBM cell lines under hypoxia. Despite expression and upregulation of anti-angiogenic factors (e.g. angiostatins) in GBM cells, they are overwhelmed by the overexpression of a larger number of angiogenic factors that shift the angiogenic balance towards the pro-angiogenic phenotype. Thus, an exogenous administration of anti-angiogenic factors may be required to improve the treatment of GBM tumors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24573635     DOI: 10.3892/or.2014.3037

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  An overview of neuro-oncology research and practice in Iran, three years with the NOSC initiative.

Authors:  Peiman Haddad; Sohrab Shazadi; Farhad Samiei; Homayoun Hadizadeh Kharrazi; Morteza Tabatabaeefar; Afshin Rakhsha; Mohammad Faranoosh; Mohammad Torabi-Nami; Ali Dadras; Atieh Liaghi; Leila Nafarieh
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.

Authors:  Dayle Rundle-Thiele; Richard Head; Leah Cosgrove; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

3.  Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers.

Authors:  Marwa E Elsherbiny; Mohammed Shaaban; Rana El-Tohamy; Islam E Elkholi; Olfat Ali Hammam; Mona Magdy; Joan Allalunis-Turner; Marwan Emara
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

Review 4.  Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.

Authors:  Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.